AR and prostate carcinoma: Studies have shown that androgens can stimulate the expression of G1 cyclins and cyclin-dependent kinases (CDKs) and decrease the expression of CDK inhibitors; however, the mechanism by which AR stimulates the cell cycle progression in prostate cancer cells remains unclear [18].